I'm making no change to my plans and my approach for my investment. Incredibly grateful for the work Daniel has put into putting Zantrene onto the right path towards helping large numbers of patients fight their cancer. This is deeply important to me.
Cancer significantly impacts large numbers of people and their families and I have been a witness to this at the coalface of treatment for some time. I believe Zantrene has a clinical and preclinical track record to make a big difference for many patients and their families.
Ann: Race Leadership Changes, page-39
-
- There are more pages in this discussion • 521 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
-0.005(0.28%) |
Mkt cap ! $303.3M | |||
| Open | High | Low | Value | Volume |
| $1.80 | $1.84 | $1.78 | $133.8K | 73.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 15072 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 1793 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |